Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-02 9:25 pm Purchase | 2025-03-31 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 7,543,007 11.210% | 918,308 (+13.86%) | Filing History |
| 2024-12-23 6:31 pm Purchase | 2024-12-23 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 6,624,699 10.300% | 6,624,699 (New Position) | Filing History |
| 2024-04-03 5:10 pm Unchanged | 2024-04-03 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-04-04 4:58 pm Unchanged | 2023-04-04 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-05-23 06:15 am Unchanged | 2022-05-23 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-10-21 6:52 pm Unchanged | 2021-10-21 | 13D | Pyxis Oncology, Inc. PYXS | Lara Sullivan, M.D. | 0 0.000% | 0 (Unchanged) | Filing |